Press Release Contact

Press release:
Nanopharmaceutics Announces Issuance of U.S. Patent Covering Oral Triapine® Formulations and Methods of Treating Cancer
September 01, 2026, 13:00 GMT

For questions about this press release, please contact the person or organization listed below.

James D Talton
Nanopharmaceutics, Inc.
Visit us on social media:
LinkedIn